Significant movement in price has been observed in Krebs Biochemicals and Industries Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Krebs Biochemicals and Industries Limited has submitted their response.
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The National Stock Exchange (NSE) wrote to Krebs Biochemicals and Industries Limited on April 8, 2026, requesting clarification on a significant movement in the company's stock price. The company submitted its response on April 10, 2026, denying any undisclosed material information or material event that would explain the price movement. The company stated it has been regularly disseminating relevant information in compliance with SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, particularly under Regulation 30.
The company denies any undisclosed catalyst for the price movement. If no material event is confirmed, the price action may be driven by speculation or market forces rather than fundamentals, which could increase volatility risk for investors.